Amenorrhea

Subscribe to Selected New Research on Amenorrhea

2677 relevant articles (95 outcomes, 221 trials/studies) found for this Disease

Description: Absence of menstruation.

Also Known As:

Postpartum Amenorrhea; Amenorrhea, Postpartum; Postpartum Amenorrheas

Relationship Network

Disease Context: Research Results

Signs and Symptoms Pathological Conditions

Pathologic Processes: 2211

Menstruation Disturbances: 137

Amenorrhea: 2677

Related Diseases

1.	Galactorrhea
2.	Oligomenorrhea
3.	Hemorrhage
4.	Infertility (Sterility)
5.	Breast Neoplasms (Breast Cancer)

Experts

1.	Warren, Michelle P: 5 articles (07/2008 - 06/2002)
2.	Miller, K K: 3 articles (04/2007 - 08/2003)
3.	Petraglia, F: 3 articles (08/2001 - 03/2000)
4.	Luisi, S: 3 articles (08/2001 - 03/2000)
5.	Schneider, Lisa F: 2 articles (07/2008 - 12/2006)
6.	Wildt, Ludwig: 2 articles (02/2008 - 10/2005)
7.	Welt, Corrine K: 2 articles (08/2007 - 09/2004)
8.	Volpe, Annibale: 2 articles (05/2006 - 11/2004)
9.	Cognetti, F: 2 articles (02/2006 - 07/2004)
10.	Ferretti, G: 2 articles (02/2006 - 07/2004)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Amenorrhea:

1.	Gonadotropin-Releasing Hormone (GnRH)FDA Link 07/01/1995 - "The LH increase with GnRH was significantly greater in the breast-feeding group than in the hypothalamic amenorrhea group (19.75 mIU/mL vs. 12.34 mIU/mL, P < 0.05)" 03/01/1976 - "Six women with secondary amenorrhea received Gn-RH, 100 mug, for 4 successive days; frequent blood samples were obtained on days 1 and 4. On day 1, the mean E2 concentration at 360 minutes was significantly greater than the mean basal level" 01/01/1998 - "In our study, GnRH-a administration prior to endometrial ablation was shown to have the following advantages: improved hysteroscopic view, reduced blood loss, absorption of uterine distending fluid and higher postoperative amenorrhea rates" 03/01/1983 - "Clinical research has shown promising results in the induction of ovulation using the pulsatile pattern of GnRH administration in patients with hypogonadotropic amenorrhea" 09/01/1997 - "OBJECTIVE: To evaluate, in a pilot study, the use and efficacy of a gonadotropin-releasing hormone (GnRH)-agonist in inducing amenorrhea in women undergoing BMT" Order ALL the reference details at left...
2.	Estrogens (Estrogen)FDA Link 07/01/1999 - "Amenorrhea was induced early in a high percentage of women using 10-cm2 patches and oral HRT, and these therapies seemed to be convenient, effective, and safe for estrogen deficiency symptoms in postmenopausal women." 05/01/1996 - "The efficacy of estrogen treatment was significantly better among cases with amenorrhea less than 1 year as compared with those longer than 1 year" 09/01/1996 - "We conclude that amenorrhea is a cause of bone loss in young women and that estrogen therapy is effective in preventing bone loss." 01/01/1991 - "Differences in plasma E2 levels between longer and shorter periods of amenorrhea may reflect dissimilar endogenous production, intake, or clearance of estrogens." 11/01/2003 - "Clinical studies of continuous combined regimens of estrogen/TMG combinations demonstrated high levels of amenorrhea" Order ALL the reference details at left...
3.	Bromocriptine (Parlodel)FDA LinkGeneric 01/01/1987 - "Bromocriptine therapy was effective in 54 of 84 cases (64%), including 6 of 15 (40%) cases with amenorrhea, 16 of 24 cases (67%) with anovulatory cycle, 9 of 15 cases (60%) with delayed ovulation and 23 of 30 cases (77%) with luteal phase defect" 01/01/2000 - "BACKGROUND: Bromocriptine improves hyperprolactinemic amenorrhea and so could also be helpful in the treatment of unexplained subfertility in women" 01/01/1996 - "BACKGROUND: Bromocriptine improves hyperprolactinemic amenorrhea and so could also be helpful in the treatment of unexplained subfertility in women" 01/01/1981 - "Partial remission of hyperprolactinemic amenorrhea after bromocriptine-induced pregnancy." 01/01/1984 - "Controlled study of bromocriptine and placebo for induction of ovulation in normoprolactinemic secondary amenorrhea." Order ALL the reference details at left...
4.	lipoarabinomannan (LAM)IBA 05/01/1996 - "Programmatic findings suggest that studies be conducted of the contribution of extended LAM to improved weaning practices, the high efficacy of continued reliance on substantial lactation and amenorrhea beyond nine months, and male involvement in LAM and breastfeeding." 12/01/1991 - "Now that more women are breastfeeding, and lactational amenorrhea is being studied worldwide, it is recognized that LAM is about 98% effective for the 1st 6 months postpartum in fully breastfeeding women" 11/01/2000 - "The purpose of this study was to assess the efficacy of the lactational amenorrhea method (LAM) for family planning among mothers who are separated from their infants by work" 11/01/2000 - "The objective of this effort was to assess the use and efficacy of the Lactational Amenorrhea Method (LAM) with reduced numbers of client-provider contacts" 11/01/2000 - "The efficacy of the lactational amenorrhea method (LAM) among working women." Order ALL the reference details at left...
5.	HormonesIBA 10/01/2000 - "The efficacy of hormone assays in the differential diagnosis of amenorrhea and menopause." 09/01/2002 - "OBJECTIVE: To study the characteristics of low bone mass in amenorrhea patients with elevated follicular stimulating hormone (FSH)" 01/01/2001 - "Seventy-three patients with secondary hypergonadotropic amenorrhea and, as control group, 144 women with acute, non-gynecological, non-neoplastic, non-hormone-related diseases were included in the study" 01/01/1954 - "Further study of genital hormone conditions in lactation amenorrhea.]" 09/01/2007 - "In patients with amenorrhea, we tested all the hormones using 1 random blood test" Order ALL the reference details at left...
6.	Clomiphene (Clomifene)FDA LinkGeneric 06/01/2007 - "OBJECTIVE: To determine if a new protocol of administration of clomiphene citrate (CC) is effective in menstrual cycle recovery in women with hypothalamic secondary amenorrhea" 03/01/1994 - "The efficacy of long term consecutive treatment of clomiphene citrate (CC) was investigated in 608 infertile women associated with anovulatory disorders (classified as WHO group II amenorrhea)" 12/01/1987 - "The study group consisted of 10 women (26 to 38 years of age) with secondary amenorrhea as a result of hypothalamic dysfunction who had failed to ovulate when given clomiphene citrate" 03/01/1987 - "The purpose of this study is to investigate the ovulatory effect of the following three methods on 40 patients with normoprolactinemic amenorrhea patients who failed to respond to clomiphene citrate (Cl) alone" 09/01/1968 - "Pituitary-function studies performed before treating secondary amenorrhea with clomiphene citrate" Order ALL the reference details at left...
7.	ProlactinIBA 11/01/1977 - "The prolactin assay is helpful in the management of patients with amenorrhea." 01/01/1991 - "Within the study group, results were independent of prolactin (HPRL) levels or amenorrhea." 04/02/1983 - "This study investigated prospectively the effect of supplementary breastfeeding on the duration of lactational amenorrhea and serum prolactin levels during prolonged breastfeeding in a group of 34 Australian mothers" 11/01/1977 - "Value of the radioimmunoassay of FSH, LH and prolactin in the pathogenetic study of secondary amenorrhea]" 09/01/2007 - "FSH, LH and prolactin (PRL) levels were assessed by ELISA in 50 cases with secondary amenorrhea and 52 age and sex-matched healthy controls from eastern Nepal" Order ALL the reference details at left...
8.	Mifepristone (RU 486)FDA Link 05/01/1996 - "OBJECTIVE: To compare use-effectiveness and side-effects of medical termination of early pregnancy by oral administration of separated doses of mifepristone 150 mg or single dose of mifepristone 200 mg followed by PG05 1 mg vaginally in 4500 healthy pregnant women with amenorrhea < or = 49 days in a phase I multicentre study" 07/01/1995 - "The 12 studies, conducted in Sweden, England, Hong Kong, Scotland, Denmark, France, and the US, differed in terms of clinical regimen (RU-486 alone or in combination with a prostaglandin suppository), sample size (range, 18-251), duration of amenorrhea (maximum, 63 days), and patient allocation (random or patient choice)" 01/01/1989 - "Four multicentre clinical trials on interruption of early pregnancy (less than or equal to 49 days of amenorrhea) using RU 486 have been conducted in China, including 2321 subjects" 03/01/1994 - "The woman must take action within the first 15 days of amenorrhea in order to arrange an RU-486 abortion" 01/01/1993 - "One hundred and twenty term women (> 37.5 weeks amenorrhea) with unripe cervixes (Bishop < 4) and with a clear clinical indication for labour induction were randomized to receive either mifepristone (RU 486) or placebo" Order ALL the reference details at left...
9.	Misoprostol (Cytotec)FDA LinkGeneric 11/01/2005 - "We are reporting the case of a woman with 8 weeks of amenorrhea who orally received a single dose of misoprostol 400 microg at midnight for ripening of cervix before uterine evacuation of an intrauterine gestational sac containing a single fetus (6.3 weeks of gestation) without cardiac activity" 02/01/2004 - "Thirty-two first-time-pregnant women with 8-12 weeks amenorrhea were randomly assigned to receive 400 microg misoprostol either orally or sublingually 3 h prior to surgery" 01/01/2000 - "Women with < or =42 days of amenorrhea, pregnancy confirmed by ultrasound, and approved request for termination received 800 microg of vaginal misoprostol once and were observed for 1 week" 04/01/1996 - "Two doses, 200 and 400 micrograms, of misoprostol, administered vaginally every 12 hours, up to four times, were tested in 101 and 133 healthy women, respectively, for interruption of pregnancies with 35 through 77 days of amenorrhea" 01/01/1996 - "One hundred and twenty nine nulliparous requesting first trimester induced abortion between 7 and 12 weeks of amenorrhea (SA) were included in the study to evaluate the effectiveness and the side effects of misoprostol in the cervical ripening before aspiration" Order ALL the reference details at left...
10.	Progesterone FDA LinkGeneric 05/01/1965 - "Studies with a new drug with a progesterone base, in the differential diagnosis of pregnancy and secondary amenorrhea]" 01/01/2006 - "In hypergonadotropic women with amenorrhea was found positive correlation between progesterone and HDL (P=0.043)" 01/01/2004 - "These functional abnormalities, which occur along a continuum from mild, luteal phase progesterone deficiency to amenorrhea, are relatively common and are often attributed to psychogenic factors (stress, anxiety, depression, or other emotional disturbance), exercise, or energy imbalance" 03/01/1997 - "Progesterone level was also significantly lower in the patients with amenorrhea and irregular cycle (0.01) and it was significantly raised in the patients with regular cycle (p < 0.05)" 10/01/1996 - "Seventy-eight percent of all subjects grew at least one new follicle over 10 mm in diameter and 46% ovulated at least once, as determined by a serum progesterone level more than 4 ng/mL. Although ovulations were significantly more common in the 10 women subjects who had less than 3 months of amenorrhea (all of whom ovulated) than in the 27 with greater than 3 months of amenorrhea (only 7 of whom ovulated (26%), P < 0.001), there was no significant difference in eventual pregnancies (2 of the 10 women with less than 3 months of amenorrhea vs. 3 of the 27 with greater than 3 months of amenorrhea, P = 0.47)" Order ALL the reference details at left...

Therapies and Procedures

1.	Contraception (Birth Control) 01/01/2003 - "Amenorrhea associated with contraception-an international study on acceptability." 01/01/2000 - "Our studies show advantages for protection of the endometrium, for contraception and a high amenorrhea rate" 05/01/1983 - "Another possible failing in the initial study is the exclusion of those women using another form of birth control during amenorrhea" 01/01/1983 - "Though extremely high compared to that of the pill, lactational amenorrhea was more useful as a fertility control mechanism because, in this study, a high proportion of women initiated pill use, but soon discontinued it because of side effects" 01/01/1969 - "Histologic and biochemical studies of amenorrhea following oral contraception." Order ALL the reference details at left...
2.	Drug Therapy (Chemotherapy) 11/01/2002 - "Whether chemotherapy-induced amenorrhea has a prognostic effect remains unclear, and further studies are warranted." 12/01/1987 - "Beneficial effects of chemotherapy induced amenorrhea was noted in four of five reported adjunctive trials" 11/01/2008 - "At the second follow-up, a mean of 28 months after chemotherapy, there was a trend toward higher amenorrhea in the ACT patients (35.7%, vs. 9.1% in the AC group)" 11/01/2008 - "RESULT(S): There was no statistically significant difference in the rates of amenorrhea at 6 months after chemotherapy (AC group, 41.7%; ACT group, 29%)" 08/01/2008 - "The risk of chemotherapy-associated amenorrhea varies according to the regime and is age-dependent" Order ALL the reference details at left...
3.	Intrauterine Devices (Intrauterine Device) 02/01/1999 - "The contraceptive efficacy of lactation is high for women breast-feeding on demand, particularly in those who remain in amenorrhea during the 6 months postpartum; in these women, elcometrine implant and IUD prevented pregnancy effectively" 04/01/2000 - "In the present study the GyneFix IUD is inserted immediately following termination of pregnancy of less than 10 weeks amenorrhea" 01/01/1996 - "On the basis of this assessment, the team recommended that efforts be directed toward strengthening the provision of methods that are often unavailable (e.g., IUDs, barrier methods, and lactational amenorrhea) rather than expanding contraceptive options" 03/01/1995 - "For breast-feeding mothers, the first choice methods are nonhormonal, including the lactational amenorrhea method, the IUD (inserted immediately or after 6 weeks), barrier methods (after 6 weeks), and sterilization" 01/01/1994 - "Users of progestogen- impregnated IUDs often experience scanty menstrual loss or amenorrhea" Order ALL the reference details at left...
4.	Hormone Replacement Therapy (Therapy, Hormone Replacement) 05/01/2001 - "Endometrial thickness may help to predict the chance of achieving amenorrhea during early hormone replacement therapy." 10/01/2003 - "SUBJECTS AND METHODS: Thirty menopausal women on hormone replacement therapy and 32 menopausal women who had never received hormone replacement therapy (HRT), matched for age and duration of amenorrhea, participated in this study" 01/01/2008 - "None of them were on hormone replacement therapy and all had had amenorrhea for more than one year" 01/01/2007 - "None of them were on hormone replacement therapy and all had had amenorrhea for more than two years" 12/01/2003 - "Sixty healthy women with 1 or more years of amenorrhea, without hormone replacement therapy and with a partner capable of intercourse were chosen from this group" Order ALL the reference details at left...
5.	Natural Family Planning Methods (Natural Family Planning) 12/01/1991 - "The efficacy of the symptothermal method of natural family planning (NFP), in the 1st 3 cycles after cessation of postpartum lactational amenorrhea was assessed in 25 women" 03/01/2001 - "Nurse-midwives' knowledge and promotion of lactational amenorrhea and other natural family-planning methods for child spacing." 06/01/1997 - "The lactational amenorrhea method avoids double protection, and thus saves resources, is especially (but not exclusively) suitable for couples interested in natural family planning and is accepted by religious authorities" 05/24/1996 - "A prospective study conducted among clients attending New Zealand Association of Natural Family Planning clinics confirmed that lactational amenorrhea is an effective means of avoiding pregnancy in the first 6 months postpartum" 12/01/1991 - "Using the lactational amenorrhea method rather than natural family planning allows them to avoid unnecessary abstinence." Order ALL the reference details at left...

Best Treatments:
Research Summary Report
on Amenorrhea

*WARNING* This specific disease subtype has a relatively small number of significant evidence outcomes. You may proceed to order anyway, or go back to the search field and enter a more general type of the target illness. Once your report has been ordered, however, we can't refund the purchase.

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 95 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>